Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-02-06

Clinical Trial Update: Threat-Avoidance Learning in Anxiety Patients

View source ↗

Summary

KU Leuven reports a clinical trial update on threat-avoidance learning in anxiety patients, focusing on panic disorder, phobias, and PTSD; the current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: KU Leuven | Conditions: Panic Disorder, Phobic Disorders | Status: UNKNOWN